Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA pseudouridylate synthase domain-containing protein 2 (RPUSD2) is an enzyme that modifies RNAs by catalyzing the isomerization of uridine to pseudouridine in target mRNAs and non-coding RNAs, a process called pseudouridylation[6][2][5]. This post-transcriptional modification alters RNA structure and can impact RNA stability, processing, and function, but there is no clear evidence directly linking RPUSD2 to a specific disease or describing it as a therapeutic drug target[6][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA pseudouridylate synthase domain-containing protein 2 (RPUSD2).